---
figid: PMC9533664__ol-24-05-13525-g00
pmcid: PMC9533664
image_filename: ol-24-05-13525-g00.jpg
figure_link: /pmc/articles/PMC9533664/figure/f1-ol-24-05-13525/
number: Figure 1
figure_title: ''
caption: Effect of Con A on the viability of human liver cancer cells and hepatocytes.
  Cell viability of (A) HCCLM3, (B) MHCC97L, (C) HepG2 and (D) MIHA cells after treatment
  with Con A (0, 1, 3, 5 and 10 µg/ml) for 12, 24 or 48 h. The data were expressed
  as the mean ± SD (n=3). *P<0.05 and **P<0.01 vs. the control group. Con A, concanavalin
  A.
article_title: Concanavalin A inhibits human liver cancer cell migration by regulating
  F-actin redistribution and assembly via MAPK signaling pathway.
citation: Haoran Jiang, et al. Oncol Lett. 2022 Nov;24(5):405.
year: '2022'

doi: 10.3892/ol.2022.13525
journal_title: Oncology Letters
journal_nlm_ta: Oncol Lett
publisher_name: D.A. Spandidos

keywords:
- cell migration
- human liver cancer
- concanavalin A
- MAPK pathway
- F-actin

---
